CSTE up +2.96% percent right now. $CSTE High is at 62.87

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CSTE up +2.96% percent right now. $CSTE High is at 62.87 and the Low 60.28 with current volume of 414,200.

Recent News posted below.

CSTE Caesarstone Sdot-Yam Ltd Recent Headline News

Oil Stocks Lift S&P 500; Alibaba Ramps Up
at Investor's Business Daily - Wed Nov 05, 12:24PM CST
Stocks remained higher Wednesday afternoon with energy stocks helping the S&P 500 outperform. The benchmark S&P 500 rose 0.5%. The Dow Jones industrial average was up 0.6%. But the Nasdaq lagged with a 0.2% gain. Volume was running mixed in the stock...
CSTE: 61.58 (+1.77), SSYS: 103.07 (-3.26), ATHM: 43.63 (-1.60), BABA: 114.56 (+2.99)

Caesarstone Reports Third Quarter 2014 Results
Business Wire - Wed Nov 05, 5:30AM CST
--Diluted EPS of $0.75; Adjusted diluted EPS of $0.76, up 63.1%
CSTE: 61.58 (+1.77)

NAHB Remodeling Index Hit All-Time High In Q3
at Investor's Business Daily - Thu Oct 23, 12:40PM CDT
In yet another sign that the housing recovery is moving along at a steady pace, the National Association of Home Builders' (NAHB) Remodeling Market Index (RMI) reclaimed its all-time high in the third quarter as remodeling activity continued to pick...
HD: 97.65 (+0.36), CSTE: 61.58 (+1.77), EXP: 86.52 (+1.53), LOW: 57.69 (+0.12)

Caesarstone Announces Date for Third Quarter Fiscal Year 2014 Results
Business Wire - Wed Oct 22, 7:30AM CDT
Caesarstone Sdot-Yam Ltd. (NASDAQ:CSTE), a manufacturer of high quality engineered quartz surfaces, today announced that it will release its earnings results for the third quarter ended September 30, 2014 on Wednesday, November 5, 2014 before the market opens.
CSTE: 61.58 (+1.77)

Caesarstone Launches Calacatta Nuvo, Available In The United States October 2014
PR Newswire - Mon Oct 13, 5:44PM CDT
Caesarstone, the leading manufacturer of premium quartz surfaces, will launch Calacatta Nuvo, a new premium design, in October 2014 throughout the United States.
CSTE: 61.58 (+1.77)

Easing Tensions Push Stocks Up In Afternoon Trade
at Investor's Business Daily - Fri Aug 08, 3:25PM CDT
The stock market finished higher after a midday rally Friday that was sparked by word that Russian troops had ended maneuvers along the Ukraine border. Volume was lower on both exchanges, according to preliminary data. The Nasdaq rose 0.8%; the S&P...
HAR: 107.08 (-0.73), AIRM: 42.95 (-3.69), UBNT: 28.78 (-5.84), CSTE: 61.58 (+1.77), SLXP: 91.47 (-47.08)

Stocks Sharply Higher As Russia Ends Maneuvers
at Investor's Business Daily - Fri Aug 08, 1:46PM CDT
The stock market sharply extended its gains heading into the last hour of trading Friday amid reports Russia ended military exercises near Ukraine. The S&P 500 and Dow industrials soared 0.9% each while the Nasdaq was up 0.8%. Volume was still...
YY: 79.50 (-1.17), CSTE: 61.58 (+1.77), TSRA: 31.56 (+0.15), SLXP: 91.47 (-47.08)

3 Stocks Spiking on Unusual Volume
at The Street - Thu Aug 07, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
CSTE: 61.58 (+1.77), EOPN: 6.23 (+0.35), WAGE: 60.46 (+5.21)

CaesarStone carves Q2 beat
at Investor's Business Daily - Wed Aug 06, 5:46PM CDT
The maker of quartz countertops, bathroom vanities and other interior surfaces says Q2 EPS climbed 9% to 58 cents, 1 cent better than forecasts. Revenue jumped 31% to $116.1 mil, well above Wall Street's $105.2 mil target and the best gain in nearly...
CSTE: 61.58 (+1.77)

CaesarStone Shares Soar As U.S. Sales Boom 55%
at Investor's Business Daily - Wed Aug 06, 12:04PM CDT
CaesarStone Sdot-Yam (CSTE) reported higher second-quarter sales and profits and raised its full-year guidance, driving shares up 11% in heavy trading volume early Wednesday. The beat by the maker of quartz countertops, bathroom vanities and other...
CSTE: 61.58 (+1.77), TREX: 44.00 (+1.01)

Caesarstone Reports Second Quarter 2014 Results
Business Wire - Wed Aug 06, 5:30AM CDT
--Reports diluted EPS of $0.51 and Adjusted diluted EPS of $0.58
CSTE: 61.58 (+1.77)

Caesarstone Announces Date for Second Quarter Fiscal Year 2014 Results
Business Wire - Wed Jul 23, 7:30AM CDT
Caesarstone Sdot-Yam Ltd. (NASDAQ:CSTE), a manufacturer of high quality engineered quartz surfaces, today announced that it will release its earnings results for the second quarter ended June 30, 2014 on Wednesday, August 6, 2014 before the market opens.
CSTE: 61.58 (+1.77)

Israel's Market Appears Unfazed By Rising Conflict
at Investor's Business Daily - Tue Jul 22, 5:07PM CDT
The conflict between Israel and Palestinians caused the U.S. Federal Aviation Administration on Tuesday to temporarily ban American flights to and from Tel Aviv's Ben Gurion International Airport after a rocket landed near the facility. The airport...
PRGO: 155.77 (+3.28), CSTE: 61.58 (+1.77), EIS: 49.37 (-0.42), TARO: 162.13 (-2.11), ISRA: 30.91 (-0.03), TSEM: 10.23 (-0.09), TEVA: 57.70 (-1.02), MLNX: 44.43 (+0.06), CHKP: 74.67 (+0.16)

Lumber Liquidators Is Getting Killed: Buy, Sell or Hold?
Jason Hall, The Motley Fool - Motley Fool - Thu Jul 10, 11:02AM CDT
Shares of flooring retailer  Lumber Liquidators  are getting destroyed this year, down more than 40% since the March peak. The company had a terrible first quarter, as winter weather pummeled many retailers, but reiterated its guidance for the...
CSTE: 61.58 (+1.77), TREX: 44.00 (+1.01), LL: 56.57 (-1.48)

CaesarStone Lawsuit: What Investors Should Know About the Future of the Stock
Brendan Mathews and Jason Moser, The Motley Fool - Motley Fool - Tue Jun 17, 3:20PM CDT
In this edition of The Motley Fool's "Ask a Fool" series, Motley Fool analysts Jason Moser and Brendan Mathews take a question from a reader who asks, "Regarding CaesarStone , does The Motley Fool have any insights into the lawsuit and/or why the...
CSTE: 61.58 (+1.77)

Universal Forest Buys 50% Stake in Upshur Forest - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 6:20PM CDT
Shares of Universal Forest Products, Inc. gained 2.92% as the company announced the acquisition of a 50% stake in Upshur Forest Products, LLC on Mar 31, 2014.
STCK: 15.34 (-0.16), CSTE: 61.58 (+1.77), UFPI: 50.18 (+0.13)

Several IPO Stocks Holding Up Well; Talmer Breaks Out
at Investor's Business Daily - Mon Mar 31, 5:26PM CDT
A number of recent IPO stocks from industries ranging from energy to banking to home improvement are holding up well despite the market's recent downturn. Talmer Bancorp (TLMR), which went public on Feb. 12, broke out above a 14.25 buy point of a...
ATHL: 58.34 (+0.11), CSTE: 61.58 (+1.77), TLMR: 14.24 (+0.16), SN: 17.38 (+0.97), KORS: 69.95 (-2.36)

Caesarstone CEO: First U.S. Plant Needed But Belated
at Investor's Business Daily - Thu Mar 27, 2:26PM CDT
Israeli quartz-surface supplier Caesarstone Sdot-Yam (CSTE) is a little behind in plans to open its first manufacturing plant in the U.S., as domestic demand for its kitchen-countertop and other products continues to grow, said CEO Yosef Shiran in an...
CSTE: 61.58 (+1.77)

Four Quality Growth Names Resilient In Tough Market
at Investor's Business Daily - Tue Mar 25, 3:56PM CDT
Growth stocks have been under a lot of pressure in recent days, but today's Stock Spotlight shows several names that haven't been under much duress lately. They're all members of top-performing industry groups to boot. That's the benefit of Stock...
GLOG: 19.74 (+0.08), AMZN: 299.86 (+3.22), CSTE: 61.58 (+1.77), WYNN: 177.18 (-1.53), PKG: 72.90 (+0.65)

Caesarstone To Support Mike Kelley Retrospective Exhibition At MOCA, Los Angeles
PR Newswire - Wed Mar 19, 3:54PM CDT
Luxury quartz countertop manufacturer Caesarstone is pleased to announce its support of the upcoming exhibition, Mike Kelley at the Museum of Contemporary Art (MOCA) in Los Angeles from March 31-July 28, 2014.
CSTE: 61.58 (+1.77)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading